Blood Preparation Market Overview, Key Trends, and Insights on Top Players

The blood preparation industry is on track for significant expansion in the coming years, driven by technological advancements and growing healthcare demands. As the need for safer blood supplies and innovative blood management systems increases, this market is set to achieve remarkable growth, supported by evolving trends and key players shaping its future.

Projected Value and Growth Potential of the Blood Preparation Market
The blood preparation market is anticipated to experience strong growth, reaching a valuation of $71.08 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 6.9% throughout the forecast period. The growth drivers include rising demand for secure blood supplies, increased investments in automated blood processing, advances in component separation technologies, heightened focus on transfusion safety, and the adoption of digital blood management systems. Key trends expected to influence the market involve greater automation in blood collection and processing, increased use of component-based transfusions, development of advanced blood storage solutions, enhanced donor screening and traceability measures, and improved cold chain management protocols.

Download a free sample of the blood preparation market report:
https://www.thebusinessresearchcompany.com/report/blood-preparation-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Notable Companies Leading the Blood Preparation Market
Several prominent organizations are actively contributing to the blood preparation sector, including AstraZeneca PLC, Sanofi, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International Inc, Pfizer Inc, Portola Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG, Boehringer Ingelheim, Celgene Corp, Shandong East Chemical Industry Co., Xiamen Hisunny Chemical Co. LTD, Merck & Co., Amgen Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., AbbVie Inc., Roche Holding AG, CSL Behring, BioMarin Pharmaceutical Inc., Genentech Inc., Sandoz International GmbH, Medtronic plc, Fresenius Kabi AG, Grifols S.A., HemaCare Corporation, and Terumo Corporation.

Strategic Moves Expanding Market Reach
In March 2023, Spain-based diagnostics and medical equipment manufacturer Werfen acquired Immucor, Inc., a U.S.-based company specializing in transfusion and transplant diagnostics, for an undisclosed sum. This acquisition enables Werfen to broaden its diagnostics portfolio by incorporating Immucor's transfusion and transplant product lines. It also strengthens Werfen's position in the blood preparation and transfusion diagnostics market, while expanding its global footprint in specialized diagnostics. Immucor is recognized for its in vitro diagnostic solutions that enhance patient-donor compatibility in blood transfusion and transplantation procedures.

The blood preparation industry is on track for significant expansion in the coming years, driven by technological advancements and growing healthcare demands. As the need for safer blood supplies and innovative blood management systems increases, this market is set to achieve remarkable growth, supported by evolving trends and key players shaping its future.

Projected Value and Growth Potential of the Blood Preparation Market
The blood preparation market is anticipated to experience strong growth, reaching a valuation of $71.08 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 6.9% throughout the forecast period. The growth drivers include rising demand for secure blood supplies, increased investments in automated blood processing, advances in component separation technologies, heightened focus on transfusion safety, and the adoption of digital blood management systems. Key trends expected to influence the market involve greater automation in blood collection and processing, increased use of component-based transfusions, development of advanced blood storage solutions, enhanced donor screening and traceability measures, and improved cold chain management protocols.

Download a free sample of the blood preparation market report:
https://www.thebusinessresearchcompany.com/report/blood-preparation-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Notable Companies Leading the Blood Preparation Market
Several prominent organizations are actively contributing to the blood preparation sector, including AstraZeneca PLC, Sanofi, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International Inc, Pfizer Inc, Portola Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG, Boehringer Ingelheim, Celgene Corp, Shandong East Chemical Industry Co., Xiamen Hisunny Chemical Co. LTD, Merck & Co., Amgen Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., AbbVie Inc., Roche Holding AG, CSL Behring, BioMarin Pharmaceutical Inc., Genentech Inc., Sandoz International GmbH, Medtronic plc, Fresenius Kabi AG, Grifols S.A., HemaCare Corporation, and Terumo Corporation.

Strategic Moves Expanding Market Reach
In March 2023, Spain-based diagnostics and medical equipment manufacturer Werfen acquired Immucor, Inc., a U.S.-based company specializing in transfusion and transplant diagnostics, for an undisclosed sum. This acquisition enables Werfen to broaden its diagnostics portfolio by incorporating Immucor's transfusion and transplant product lines. It also strengthens Werfen's position in the blood preparation and transfusion diagnostics market, while expanding its global footprint in specialized diagnostics. Immucor is recognized for its in vitro diagnostic solutions that enhance patient-donor compatibility in blood transfusion and transplantation procedures.

Innovations and Technology Trends Reshaping the Blood Preparation Industry
Companies involved in the blood preparation market are increasingly focusing on integrating brain-computer interface (BCI) technology to improve treatment precision and personalize patient care, especially for neurological conditions. BCIs facilitate direct communication between the brain and external devices by interpreting neural signals and translating them into commands that control computers, prosthetics, or therapeutic systems. These interfaces are often embedded into neuromodulation or rehabilitation devices, allowing real-time monitoring and adaptive therapy based on brain activity.

For example, in February 2025, Medtronic plc, a U.S.-based medical technology firm, received FDA approval for its BrainSense Adaptive Deep Brain Stimulation (aDBS) system and BrainSense Electrode Identifier (EI). This marked the largest commercial launch of BCI technology. The closed-loop neuromodulation system continuously monitors brain activity and adjusts stimulation automatically, optimizing therapy for Parkinson's disease. Clinical trials showed improved symptom control, fewer motor fluctuations, and better patient outcomes compared to traditional deep brain stimulation methods.

Key Segmentation Insights in the Blood Preparation Market
The blood preparation market is broadly categorized into several segments:
1) By Product Type: Whole Blood, Blood Components, and Blood Derivatives
2) By Antithrombotic and Anticoagulant Types: Platelet Aggregation Inhibitors, Fibrinolytics, and Anticoagulants
3) By Application: Transfusion, Diagnostics, and Research
4) By End User: Hospitals, Clinics, Blood Banks, and Other Users

Further details on subsegments include:
- Whole Blood: Fresh Whole Blood and Stored Whole Blood
- Blood Components: Red Blood Cells (RBC), Platelets, Plasma, and White Blood Cells (WBC)
- Blood Derivatives: Immunoglobulins, Coagulation Factors, Albumin, and Fibrinogen

These classifications provide a comprehensive view of the market's product offerings and end-use applications, highlighting the diversity and specialization within the blood preparation industry.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.